Samy Y. Elkhawaga

Statistics

Publications

Citations

H-Index

Active since

2021

Affiliations

Al-Azhar University(Current)

Cairo University

Samy Y. Elkhawaga is an author at Al-Azhar University specializing in tyrosine kinase inhibitors, pyrimidine analogues, and autoimmune disease susceptibility genes.

ORCID

Publications per year

2021–2023

Publications

In vitro and in silico evaluation of new thieno[2,3-d]pyrimidines as anti-cancer agents and apoptosis inducers targeting VEGFR-2

Souad A. El‐Metwally, Abdelrahman A. Abuelkhir, Hazem Elkady et al. · Computational Biology and Chemistry · 2023 · 16 citations

Medicine, Medicinal Chemistry, Oncology +13

NFKB1 promoter –94 insertion/deletion ATTG polymorphism (rs28362491) is associated with severity and disease progression of rheumatoid arthritis through interleukin-6 levels modulation in Egyptian patients

Samy Y. Elkhawaga, Maher H. Gomaa, Mohsen M. Elsayed et al. · Clinical Rheumatology · 2021 · 12 citations

Life Sciences, Genetics, Immunology +14

Design and Synthesis of Novel Pyrazolopyrimidine Candidates As Promising EGFR-T790M Inhibitors and Apoptosis Inducers

Ahmed A. Abdel Gaber, Marwa Sharaky, Ayman Abo Elmaaty et al. · Future Medicinal Chemistry · 2023 · 11 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

1–3 of 3